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Chromosome 3p was reported by previous studies as one of the
regions showing strong evidence of linkage with schizophrenia.
We performed a fine-mapping association study of a 6-Mb high-
LD and gene-rich region on 3p in a Southern Chinese sample of
489 schizophrenia patients and 519 controls to search for suscep-
tibility genes. In the initial screen, 4 SNPs out of the 144 tag SNPs
genotyped were nominally significant (P< 0.05). One of the most
significant SNPs (rs3732530, P¼ 0.0048) was a non-synonymous
SNP in the neuroglycan C (NGC, also known as CSPG5) gene,
which belongs to the neuregulin family. The gene prioritization
program Endeavor ranked NGC 8th out of the 129 genes in the
6-Mb region and the highest among the genes within the same LD
block. Further genotyping of NGC revealed 3 more SNPs to be
nominally associated with schizophrenia. Three other genes
(NRG1, ErbB3, ErbB4) involved in the neuregulin pathways were
subsequently genotyped. Interaction analysis by multifactor di-
mensionality reduction (MDR) revealed a significant two-SNP
interaction between NGC and NRG1 (P¼ 0.015) and three-SNP
interactions between NRG1 and ErbB4 (P¼ 0.009). The gene NGC
is exclusively expressed in the brain. It is implicated in neuro-
development in rats and was previously shown to promote neurite
outgrowth. Methamphetamine, a drug that may induce psychotic
symptoms, was reported to alter the expression of NGC. Taken
together, these results suggest that NGC may be a novel candidate
gene, and neuregulin signaling pathways may play an important
role in schizophrenia.  2009 Wiley-Liss, Inc.
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INTRODUCTION
Schizophrenia (SZ [MIM 181500]) is a severe, common neuro-
developmental psychiatric disorder affecting nearly 1% of the
human population [Sawa and Snyder, 2002]. Although the disorder
has high heritability (around 80% as shown by twin studies)
[Cardno and Gottesman, 2000], the overall evidence from family
and linkage studies indicates complex inheritance with the involve-
ment of multiple genetic loci. Linkage and association studies have
so far identified a few susceptibility genes of modest effect, includ-
ing neuregulin 1 (NRG1), dysbindin (DTNBP1), and D-amino-acid
oxidase (DAAO) [Harrison and Weinberger, 2005].
Chromosome 3p is one region with evidence of linkage with SZ,
first implicated by a genome-wide linkage scan [Pulver et al., 1995]
which identified 3p and 8p to have the two highest LOD scores (2.34
and 3.00, respectively). Another linkage study on targeted chromo-
somal regions yielded a two-point LOD score of1.5 in support of
linkage to 3p [Maziade et al., 2001]. The best evidence of linkage to
3p came from the meta-analysis performed by Lewis et al. [2003].
This meta-analysis included data from 20 schizophrenia genome
scans and employed a rank-based approach to combine evidence
from different scans. The second bin on chromosome 3p showed
strong statistical significance for linkage, ranking 2nd in the un-
weighted analysis and 3rd in the weighted analysis (in which each
study was weighted by the square root of its sample size).
In this study, we attempt to screen chromosome 3p for
susceptibility genes for SZ in a Southern Chinese sample of
489 schizophrenia patients and 519 controls. We decided to con-
centrate on the 47–53 Mb region of 3p, which has high levels of
linkage disequilibrium (LD) and gene density (see Fig. 1). The
region was interrogated by tag SNPs selected using a clustering
algorithm [Ao et al., 2005] which has been further improved by
using both LD and biological information in the selection process
[Sham et al., 2007]. Using these tools, we have conducted a high-
density association study of this 47–53 Mb region of 3p to search for
SZ susceptibility genes. Candidate genes that contain significant
SNPs from this screen were then subjected to further exploration
which included the genotyping of additional SNPs in these genes
and their interacting partners.
MATERIALS AND METHODS
Case–Control Sample
Four hundred eighty-nine patients with schizophrenia diagnosed
by DSM-IV were recruited from mental hospitals in Hong Kong.
Five hundred nineteen controls without serious mental disorders
were recruited from the community. Details of sample collection
can be found elsewhere [Chen et al., 2001].
Assay Design and Genotyping
We employed the Sequenom MassARRAY system for assay
design and genotyping, using SpectroDESIGNER software version
2.0.0.17. Genotyping was carried out by primer extension and
MALDI-TOF mass spectrometry. For quality control, 20 samples
were duplicated and 4 negative controls were included in each 384-
well plate. A successful assay was defined as one with (i)  90% of
genotyping calls; and (ii) control genotypes not significantly devi-
ating from the Hardy–Weinberg equilibrium (P> 0.01).
Initial Association Screen
For tag SNP selection, we downloaded genotype data on 1693 SNPs
in the 3p region typed on the HapMap Asian population (JPT
and CHB), data release 2005–03_16a_phaseI (Build 34). The
CLUSTAG [Ao et al., 2005] program, which employs an agglom-
erative clustering algorithm, was used for the selection of tag SNPs,
with the R2 threshold set at 0.8. If a SNP failed in the assay design, it
was replaced by the second best SNP within the same cluster. From
the 814 common SNPs (those of minor allele frequency>5%), we
selected 218 tag SNPs and successfully designed genotyping assays
for 214 of them. Of these, 162 SNPs genotyped passed the quality
control criteria. The average genotype call rate was 96%. Eighteen
FIG. 1. The top figure is a LD plot of 41–59 Mb on chromosome 3. The plot shows a high LD region in the middle (47–53 Mb, boxed region). The figure
below is the ideogram of chromosome 3 with plots of gene density and SNP density. The 6-Mb high LD region is highlighted and shows a high gene
density. [Color figure can be viewed in the online issue, which is available at www.interscience.wiley.com.]
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SNPs with minor allele frequency under 1% were discarded, leaving
144 markers for the association analyses. To ensure that the
remaining markers still captured the variation in the 3p region
adequately, we reassessed the coverage of these 144 tag SNPs using
Haploview. The proportion of the genetic variation captured was
calculated with reference to HapMap release 21. We employed
aggressive tagging with 2- and 3-marker haplotype tags. The
original 144 tag SNPs captured 76% of the alleles in the linkage
region at r-squared 0.8. The average R2 is 0.948.
Statistical Analyses for Association
The programs WHAP (ver 2.06) [Saxena et al., 2007] (http://
pngu.mgh.harvard.edu/purcell/whap/) and UNPHASED (ver
3.09) [Dudbridge, 2003] were used to screen all the 144 markers
for both allelic and haplotype-based association. Genotype data
were phased and haplotype frequencies were estimated using a
standard E-M approach implemented in both programs. The
programs performed a regression-based haplotype association test
for all haplotypes. Moving window analyses were performed with
single marker and with two to four consecutive markers as hap-
lotypes. The false discovery rate (FDR) approach [Benjamini and
Hochberg, 1995] was used to correct for multiple testing. Odds
ratios and confidence intervals were calculated for the significant
markers. LD statistics between markers were calculated and rep-
resented graphically by HaploView [Barrett et al., 2005].
Prioritization of Genes Using Bioinformatics Tools
To incorporate biological significance into the consideration of
potential candidate genes, we used the software Endeavor [Aerts
et al., 2006] to rank all the genes included in our initial screen.
Endeavor prioritizes candidate genes underlying diseases or bio-
logical pathways by their similarity to a set of ‘‘training genes’’
which are specified by the user. Training genes are those with
previous evidence for association with a particular disease or
pathway. The program assumes that genes involved in the same
disease or pathway are likely to share features with the known
candidates. The program employs up to 12 different data sources,
such as pathway membership in KEGG, annotations in Gene
Ontology, sequence similarity and protein interactions to assess
the properties of the training set. The final ranking is obtained by
combining all data sources using order statistics. Endeavor is
among the most extensively validated software designed for
this purpose. For example, it has been validated by leave-one-out
cross-validations using 703 disease and pathway genes, and by
in vivo studies in zebrafish [Aerts et al., 2006]. In the present
study, a training set was selected from the SZgene database
(http://www.schizophreniaforum.org/res/sczgene/default.asp ac-
cessed 17th September 2007) and a review article on SZ genetics
by Straub and Weinberger [2006]. Genes in the ‘‘Top Results’’ list
from SZgene, all of which have at least one variant showing a
nominally significant result in meta-analyses, were selected, as well
as those listed in Table I in Straub and Weinberger’s review (list of
training genes is shown in Table I). To ensure the reliability of the
rankings, we also repeated our analyses leaving one of the training
genes out each time. This ensures that the results would not be
seriously affected by individual training genes and protects against
the risk that some training genes may later turn out to have
no association with schizophrenia. We included all genes in the
47–53 Mb region on chromosome 3p as the testing set.
Weighted FDR Analysis
The rankings obtained from Endeavor were also used to weight the
P-values obtained from the initial screen of the linkage region in a
weighted FDR approach [Roeder et al., 2006]. The weight is based
on the rankings of the 60 genes containing the genotyped markers.
Different degrees of emphasis on biological information could be
specified using different functions of the rankings; we used weights
that were either directly proportional to ranking (linear weights) or
to ranking squared (quadratic weights). Variants belonging to the
same gene were given the same weighting. SNPs lying outside a gene
were regarded as belonging to the nearest gene, provided that
the gene was within 50 kb of the SNP.
Follow-Up Analyses of Identified Genes
For follow-up analyses, we used the WCLUSTAG [Sham et al.,
2007] program for selection of additional tag SNPs within the most
promising gene from the initial screen (which was neuroglycan C,
see below). WCLUSTAG allows users to adjust the clustering
threshold according to the location or presumed functional signifi-
cance of the SNPs. In this study, the R2 tagging threshold was set to
be 1.0 for SNPs in coding regions, 0.8 for SNPs within 50UTR,
30UTR, 50upstream and 30downstream regions, and 0.3 for introns.
We also genotyped possible interacting partners of neuroglycan C
(NGC), namely NRG1, ErbB3, and ErbB4. NRG1 is the first member
in the neuregulin family and is one of the most established suscep-
tibility genes for SZ [Harrison and Law, 2006]. ErbB3 is a direct
interacting partner of NGC while both ErbB3 and ErbB4 are binding
receptors for NRG1 (see Discussion Section).
Potential interactions among genetic markers in the same or
different genes were assessed by multifactor dimensionality
reduction (MDR) [Ritchie et al., 2001; Hahn et al., 2003], a
model-free approach for detecting interactions between loci in
association studies. MDR reduces the multilocus genotype data to
one dimension by classifying each multilocus genotype as either
high-risk or low-risk by the ratio of affected individuals to unaf-
fected individuals with that genotype. We used the standard 10-fold
cross validation to evaluate the accuracy of prediction of 2-SNP and
3-SNP combinations and permutation tests to calculate empirical
P-values. In order to test whether the interaction is significant over
the main effects and whether the results are similar under a
parametric approach, we also carried out logistic regression for
interacting SNP pairs identified by MDR. The SNPs were coded in 0,
1, and 2 under the assumption of an additive model. The overall
significance of interaction was assessed by a likelihood ratio test,
comparing the full model (with all main effects and interaction
terms) with the reduced model (with only the main effects).
Bioinformatics Analyses of Candidate Genes
We looked for functional domains that could be relevant to the
disease for SNPs that showed statistically significant association.
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SNP sequences were downloaded from public databases. The
sequences were submitted to Pfam [Finn et al., 2006], a public
protein family database. Pfam has a large collection of multiple
sequence alignments and hidden Markov models covering many
common protein domains and families. The Wise2 software
package (http://www.ebi.ac.uk/Wise2/) was used to blast DNA
and protein sequences. Multiple species alignment was obtained
for the domains to which our significant markers belong.
For the gene of interest, the domain structure of its protein was
obtained from UniProt (Universal Protein Resource) (http://
www.pir.uniprot.org/). Gene expression information was obtained
from the Stanford Microarray Database (http://genome-www5.
stanford.edu/).
RESULTS
Association Screen Identified NGC as a Promising
Candidate Gene for Schizophrenia
In single marker association analyses, four SNPs were found to be
nominally significant at P< 0.05 (Fig. 2 and Table II), although the
global permutation P-value of the most significant of the 144 tests
was only 0.3107. The best two markers rs3732530 (P¼ 0.0048) and
rs4858867 (P¼ 0.0040) were situated in exon 2 in neuroglycan C
(NGC, also known as chondroitin sulfate proteoglycan 5, or
CSPG5) and intron 13 in microtubule associated protein 4
(MAP4), respectively. The R2 between these 2 markers is 0.246.
The false discovery rate (or q-value) for the top 2 markers was 0.343.
P-values for all 144 markers in the initial screen are shown in
Supplementary Table I.
We further screened all possible haplotypes with sizes of two,
three, and four markers (Supplementary Table II). Haplotype
analyses did not reveal any results with stronger significance than
single locus analysis, with the best results being for haplotypes that
clustered around the most significant SNPs in single-marker analy-
ses. The best haplotype was formed by the markers rs3732530 and
rs4858867 (P¼ 0.0066).
We examined the LD structure of the associated regions based
on HapMap data and noted that most of the significant signals
from single-marker and haplotype analyses were clustered
around an LD block containing the genes NGC, SMARCC1,
DHX30, and MAP4. Our results suggested associations to
TABLE I. Training Set of Genes for Endeavor Analysis (Alternative Names for Genes Are Shown in Brackets)
Gene name Gene symbol
1 Neuregulin-1 NRG1
2 Disrupted in schizophrenia 1 DISC1
3 Regulator of G-protein signaling 4 RGS4
4 Proline oxidase, mitochondrial precursor (Proline dehydrogenase) PRODH
5 Dysbindin (Dystrobrevin-binding protein 1) DTNBP1
6 D-amino-acid oxidase DAO (DAAO)
7 Catechol O-methyltransferase COMT
8 D(3) dopamine receptor DRD3
9 Neuronal acetylcholine receptor subunit alpha-7 precursor CHRNA7
10 RAC-alpha serine/threonine-protein kinase (protein kinase B) AKT1 (PKB)
11 D(2) dopamine receptor (dopamine D2 receptor) DRD2
12 Metabotropic glutamate receptor 3 precursor GRM3
13 Serine/threonine-protein phosphatase 2B catalytic subunit gamma PPP3CC
14 Glutamate decarboxylase 1 GAD1
15 Receptor tyro sine-protein kinase erbB-4 precursor ERBB4
16 Fasciculation and elongation protein zeta 1 FEZ1
17 Thioredoxin domain-containing protein 5 precursor TXNDC5 (MUTED)
18 Orofacial cleft 1 candidate 1 OFCC1 (MRDS1)
19 D-amino acid oxidase activator (protein G72) DAOA (G72)
20 Glutamate [NMDA] receptor subunit epsilon 2 precursor (N-methyl D-aspartate receptor subtype 2B) GRIN2B (NMDAR2B)
21 Gamma-aminobutyric-acid receptor subunit beta-2 precursor GABRB2
22 Tryptophan 5-hydroxylase 1 TPH1
23 Sodium-dependent serotonin transporter (5HT transporter) SLC6A4
24 Interleukin-1 beta precursor IL1B
25 Dopamine receptor D4 DRD4
26 Methylenetetrahydrofolatereductase MTHFR
27 Plexin-A2 precursor (Semaphorin receptor OCT) PLXNA2
28 Apolipoprotein E precursor APOE
29 D(1A) dopamine receptor DRD1
30 Haptoglobin precursor HP
31 Cellular tumor antigen p53 (tumor suppressor p53) TP53 (P53)
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this block, but could not distinguish the exact gene implicated
in the disease due to high LD in the region. Hence we made use
of the results from Endeavor to further prioritize genes in this
region.
Using all 31 training genes, Endeavor ranked NGC 8th, MAP4
29th, DHX30 57th, and SMARCC1 67th out of the 129 genes in
the 6MB region scanned (Table III). The NGC SNP rs3732530
had the lowest weighted P-value among the 144 genotyped SNPs.
The weighted FDRs for rs3732530 were 0.411 and 0.302 under
linear and quadratic weighting schemes, respectively. We repeated
the analysis leaving each of the training genes out and calculated
the average ranks. They were in general similar to the original
ranks. The average rank of NGC was 9th and the actual leave-one-
out rank ranged from 6th to 15th. The marker with the lowest
weighted P-value using the average ranks was again rs3732530,
having weighted FDRs of 0.413 and 0.303 respectively under linear
and quadratic weighting schemes. We also calculated the weighted
P-values in the least favorable scenario when NGC had the lowest
leave-one-out rank (15th). Notably, the NGC SNP rs3732530 still
achieved the lowest weighted P-value among the 144 genotyped
markers.
As NGC was ranked by Endeavor as the most functionally
relevant among the four genes in the implicated LD block and
previous biological experiments also suggested a role of NGC in
neurodevelopment (see Discussion Section), we believed that it is
the most promising candidate in the region and further genotyped
this gene and its interacting partners.
Follow-Up and MDR Analyses of NGC, NRG1,
ErbB3, and ErbB4
In the follow-up phase, four out of seven markers tested within
NGC showed nominally significant signals (P< 0.05). The best SNP
in this gene (rs3732530) survived permutation correction for
multiple testing within the gene (corrected P¼ 0.024). Two hap-
lotypes were also nominally significant and the best haplotype was
formed by markers rs3732530 and rs12489865 (P¼ 0.0179)
(Table IV, Supplementary Tables III and IV).
For ErbB4, two markers (rs2371276 and rs13032249) were found
to be significant with P-values 0.0063 and 0.0465, respectively. Four
haplotypes also showed P< 0.05. Although the best ErbB4 marker
did not withstand permutation correction, the q-values for the best
two markers (NGC_5 and ErbB4_11) in the second stage of
association analysis (considering all 58 SNPs) were 0.183. None
of the NRG1 markers was significant when considered individually.
However, three haplotypes showed nominal significance. The
P-value for the most significant haplotype was 0.011, although
this was not significant after permutation correction. No significant
result was found in the three markers genotyped in ErbB3
(Table IV).
In MDR analyses, five marker combinations were shown to be
statistically significant by permutation tests which corrected for the
inclusion of multiple SNPs. The results were significant at an FDR of
0.05. The best two-SNP model was composed of variants from NGC
and NRG1, while the best three-SNP model included SNPs from
FIG. 2. Statistical significance of the 144 markers in the initial association screen. The four markers showing nominal significance (P< 0.05) are
circled. [Color figure can be viewed in the online issue, which is available at www.interscience.wiley.com.]
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ErbB4 and NRG1. Only the best 2-SNP model comprising NGC and
NRG1 SNPs was also significant when logistic regression was
employed (Table V).
Bioinformatics Analysis for NGC
None of the significant NGC SNPs had flanking sequences that lie in
any structural units, except one, rs3732530, which was found to be
in the chondroitin sulfate attachment domain (accession number
PF06566 in the Pfam database). This SNP is a non-synonymous
SNP, in which the change of allele from T to G results in an amino
acid change from Val to Gly. The sequence of this domain is
highly conserved among mouse, rat, human, and chicken, with an
additional leucine- and proline-rich sequence attached to the
chondroitin sulfate chains in chicken. This domain together with
the cytoplasmic domain form the major part of the NGC protein.
DISCUSSION
Using a fine-mapping strategy and a range of statistical tools such as
WCLUSTAG, weighted FDR and MDR, we identified neuroglycan
C (NGC), a membrane-spanning chondroitin sulfate proteoglycan,
which is exclusively expressed in the brain, as a novel candidate gene
for SZ. This finding is supported by both statistical and biological
evidence.
In the association analyses, a non-synonymous SNP in NGC
(rs3732530) showed a moderately high level of significance which
survived permutation correction considering all the examined
variants in the gene. Although a global permutation test for all
144 markers in the first screening stage did not show significance,
the weighted FDR for the best two markers (in NGC and MAP4) was
only 0.223, using quadratic weighting according to the rankings
from Endeavor. It is noteworthy that NGC ranked 8th out of the
129 genes in the 6-MB region scanned and the highest among the
genes lying in the same LD block.
Importantly, a large body of evidence from biological experi-
ments also supports a role for NGC in the pathogenesis of SZ. NGC
is exclusively expressed in the brain, and was discovered in the
developing rat brain. NGC is first expressed at embryonic day 16
and the expression level continues to rise with a peak at the early
postnatal period, coinciding with the period of active neurite
formation and synaptogenesis in the rat brain. Expression of the
gene decreases as the brain matures [Watanabe et al., 1995]. NGC is
expressed in association with axons and dendrites in the CNS
during development [Schumacher et al., 1997; Aono et al.,
2000]. Nakanishi et al. [2006] showed that a recombinant ectodo-
main of NGC core protein enhances neurite outgrowth in
rat neurons, supporting the idea that NGC is involved in
neurodevelopment.
In addition, CALEB (chicken acidic leucine-rich EGF-like do-
main containing brain protein), a chick homolog of NGC, dem-
onstrates biological functions associated with pathogenesis of
schizophrenia. Expression of CALEB is restricted to the developing
and adult nervous system. The component containing chondrotin
sulfate was expressed in the embryonic nervous system and down-
regulated in the adult. CALEB is involved in neurite formation;
antibodies against CALEB result in impairment of neurite extension
in a permissive environment [Schumacher et al., 1997]. Another
TABLE II. Initial Association Screen of 144 Markers (Only Significant Results Shown)
Marker Gene
Allele
LR chisq P-value OR (95%CI)A C
12 NGC Cases 605 (0.646) 331 (0.354) 7.952 0.0048 1.30 (1.08–1.57)
rs3732530 Controls 572 (0.584) 408 (0.416)
Marker Gene
Allele
LR chisq P-value OR (95%CI)C T
14 SMARCC1 Cases 271 (0.281) 695 (0.720) 4.400 0.0359 1.23 (1.01–1.49)
rs4274776 Controls 329 (0.324) 687 (0.676)
Marker Gene
Allele
LR chisq P-value OR (95%CI)C T
17 MAP4 Cases 777 (0.873) 113 (0.127) 8.287 0.0040 1.46 (1.13–1.90)
rs4858867 Controls 762 (0.825) 162 (0.175)
Marker Gene
Allele
LR chisq P-value OR (95%CI)A T
33 SCOTIN Cases 795 (0.848) 143 (0.153) 5.084 0.0241 1.31 (1.04–1.66)
rs6442126 Controls 822 (0.809) 194 (0.191)
LR chisq, likelihood ratio chi-square; NGC, neuroglycan C (also named CSPG5, chondroitin sulfate proteoglycan 5); SMARCC1, SWI/SNF related, matrix associated, actin dependent regulator of
chromatin, subfamily c, member 1; MAP4, microtubule associated protein 4.
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TABLE III. Endeavor Ranks of All Genes in the 6 Mb Region
Scanned
Gene symbol Overall rank Average rank
GRM2 1 1.42
PLXNB1 2 1.84
SLC26A6 3 4.16
MST1 4 4.06
ITIH4 5 5.65
MST1R 6 5.74
GNAI2 7 6.39
NGC 8 8.90
BSN 9 9.13
IMPDH2 10 11.55
AMT 11 11.58
CAMKV 12 16.23
SEMA3B 13 14.45
LAMB2 14 12.61
COL7A1 15 15.35
MAPKAPK3 16 14.97
ITIH1 17 19.84
USP4 18 23.39
SETD2 19 20.90
STAB1 20 19.45
DAG1 21 17.90
GNL3 22 21.97
TLR9 23 22.23
PRKAR2A 24 22.84
SHISA5 25 26.45
CDC25A 26 28.48
BAP1 27 27.00
NBEAL2 28 30.77
MAP4 29 31.68
RASSF1 30 30.61
ACY1 31 32.16
QARS 32 34.52
RHOA 33 30.81
DUSP7 34 33.06
ZMYND10 35 37.48
HYAL1 36 38.97
DOCK3 37 38.00
SCAP 38 38.00
TUSC4 39 46.42
QRICH1 40 40.35
HYAL2 41 41.16
CACNA2D2 42 44.52
NISCH 43 46.55
ARIH2 44 45.42
PCBP4 45 40.23
RAD54L2 46 49.19
UQCRC1 47 41.65
SLC25A20 48 50.48
TREX1 49 49.65
USP19 50 62.19
PBRM1 51 53.26
SEMA3F 52 49.74
UBE1L 53 56.26
P4HTM 54 52.32
IHPK1 55 52.84
SLC38A3 56 54.71
DHX30 57 55.16
TEX264 58 62.32
TUSC2 59 59.19
CISH 60 60.77
HYAL3 61 56.13
ABHD14A 62 51.32
SFMBT1 64 65.48
HEMK1 65 67.32
SEMA3G 66 64.03
SMARCC1 67 64.00
ITIH3 68 69.68
GPX1 69 59.00
RBM5 70 75.35
IHPK2 71 71.13
NEK4 72 78.29
KIF9 73 78.00
PPM1M 74 80.84
GLYCTK 75 74.74
KLHL18 76 75.35
TNNC1 77 72.35
MON1A 78 75.68
GNAT1 79 76.90
PARP3 80 75.29
VPRBP 81 82.26
PTPN23 82 78.19
NT5DC2 83 81.77
RPL29 84 83.00
TMEM89 85 90.32
RNF123 86 85.10
CAMP 87 77.19
APEH 88 88.77
TMEM115 89 86.68
WDR51A 90 90.97
CCDC36 91 89.81
GLT8D1 92 86.35
RBM15B 93 93.19
RBM6 94 96.90
TRAIP 95 96.26
AMIGO3 96 96.16
C3orf71 97 97.90
WDR6 98 100.35
ABHD14B 99 101.32
FBXW12 100 93.35
NICN1 101 101.84
TCTA 102 104.10
PFKFB4 103 107.68
SPCS1 104 102.55
C3orf62 105 105.03
GPR62 106 93.61
PHF7 107 107.00
ALAS1 108 108.23
NME6 109 106.35
CCDC71 110 109.16
CYB561D2 111 112.87
RRP9 112 118.06
ZNF589 113 115.00
GMPPB 114 112.97
DALRD3 115 115.32
TMEM113 116 115.39
TABLE III. (Continued)
Gene symbol Overall rank Average rank
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study [Juttner et al., 2005] showed that CALEB-deficient mice
exhibit impaired synapse function in early postnatal stages.
NGC has been implicated in the effects of methamphetamine and
cocaine, two drugs that are known to produce psychotic symptoms
such as paranoid delusions and hallucinations. Ishikawa et al.
[2006] reported that repeated administration of methamphet-
amine significantly increased mRNA levels of NGC in numerous
rat brain areas, such as frontal cortex, nucleus accumbens and
hippocampus. Moreover, NGC protein levels in the nucleus ac-
cumbens increased in rats repeatedly treated by methamphetamine.
Up-regulation in both mRNA and protein levels of NGC was also
found in chronic cocaine-treated rats [Toda et al., 2002].
NGC possesses an EGF-like extracellular domain and is an active
growth factor. It is considered to be the sixth member of the
neuregulin family, as it acts as a direct ligand for ErbB3
tyrosine kinases that can transactivate ErbB2 [Kinugasa et al.,
2004]. Neuregulin 1 (NRG1), the first member of the neuregulin
family, is a strong candidate gene for SZ. It is involved in a large
variety of processes that may be relevant to the pathogenesis of SZ,
such as neuronal migration, oligodendrocyte development, myelin
formation, and neurotransmitter receptor (particularly NMDA
receptor) function [Corfas et al., 2004; Harrison and Law, 2006].
Being another member of the neuregulin family, NGC might share
some of the functional properties with NRG1 and hence may be
involved in the pathogenesis of SZ.
NRG1 has been reported to be associated with SZ in different
populations. The initial study on NRG1 by Stefansson et al. [2002]
and many other studies [Yang et al., 2003; Corvin et al., 2004; Hall
et al., 2004; Li et al., 2004, 2006; Tang et al., 2004; Zhao et al., 2004]
identified SNPs and haplotypes near the 50 end of the gene to be
associated with SZ. On the other hand, the 30 end region was also
implicated in a few studies [Yang et al., 2003; Li et al., 2004;
Petryshen et al., 2005], two involving Chinese samples [Yang
CCDC51 117 112.19
C3orf54 118 117.65
TMEM103 119 118.74
IQCF2 120 119.35
UCN2 121 118.97
DNAH1 122 119.45
KLHDC8B 123 123.35
IQCF1 124 123.90
C3orf60 125 124.61
C3orf45 126 125.10
CDH29 127 127.16
STGC3 128 127.81
C3orf18 129 125.23
TABLE III. (Continued)
Gene symbol Overall rank Average rank
TABLE IV. All Markers Showing Nominal Significance (P< 0.05) in Single SNP (Allelic or Genotypic) or Haplotype Analyses in the Follow-Up
Phase
Marker number rs number
P-value
Genotypic Allelic 2-marker 3-marker 4-marker
NGC
NGC_3 rs10865948 0.090 0.029
NGC_4 rs11716779 0.230 0.538 0.040
NGC_5 rs3732530 0.007 0.005 0.018
NGC_6 rs12489865 0.022 0.017
NGC_7 rs3755637 0.091 0.046
NRG1
NRG1_5 rs1531746 0.664 0.801 0.016
NRG1_6 rs10503904 0.594 0.658
NRG1_9 rs6986716 0.243 0.094 0.011 0.020
NRG1_10 rs10503915 0.055 0.286
NRG1_11 rs7016691 0.928 0.711
ErbB4
ErbB4_10 rs2272024 0.994 0.982 0.036
ErbB4_11 rs2371276 0.002 0.006 0.033 0.040
ErbB4_12 rs10205553 0.834 0.945
ErbB4_13 rs6435659 0.432 0.986
ErbB4_14 rs6435660 0.067 0.132
ErbB4_17 rs6435665 0.241 0.118 0.017
ErbB4_18 rs6435670 0.941 0.757
ErbB4_19 rs839530 0.551 0.278
ErbB4_20 rs12478950 0.227 0.265
P-values for haplotype analyses are shown next to the 1st SNP in the sliding window.
P-values that are nominally significant (<0.05) are in bold. For haplotype analyses, only nominally significant results are shown.
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et al., 2003; Li et al., 2004]. The 50 and 30 regions containing
susceptibility variants were designated regions A and B by Thomson
et al. [2007]. Interestingly, the risk haplotypes identified in
this study are between regions A and B, a region of this large
gene (1.1 Mb) that most previous studies have not thoroughly
screened, except Thomson et al. [2007] and Benzel et al. [2007].
Further comprehensive studies of NRG1 may be warranted, espe-
cially in non-Caucasian groups.
NRG1-ErbB signaling regulates a variety of processes that may be
involved in SZ [Corfas et al., 2004]. ErbB3 and ErbB4 are hence good
functional candidate genes for SZ. ErbB3 is a direct interacting
partner of NGC. Three microarray studies [Hakak et al., 2001;
Tkachev et al., 2003; Aston et al., 2004] have shown that ErbB3, as a
myelination-related gene, has altered expression in the post-mor-
tem brains of schizophrenic patients. Oligodendrocyte dysfunction
and disturbances in myelination are receiving increasing attention
as important mechanisms underlying SZ [Karoutzou et al., 2008].
ErbB3 has also been examined previously in three association
studies [Benzel et al., 2007; Kanazawa et al., 2007; Watanabe
et al., 2007], but no susceptibility variants have been identified.
We also failed to find any positive associations in ErbB3 in this
study.
ErbB4 is another biological candidate for SZ and association
studies have been performed on this gene. Silberberg et al. [2006]
identified three SNPs in ErbB4 which showed marked differences in
allele and genotype frequencies between schizophrenic patients and
controls. Benzel et al. [2007] screened 109 SNPs in ErbB4 and found
14 SNPs with P-values<0.05 in either genotypic or allelic tests. Our
study is the first to investigate ErbB4 polymorphisms in an Asian
population. The two nominally significant SNPs and four-marker
haplotype did not withstand permutation correction, but the FDR
of the most significant ErbB4 SNP was nevertheless 0.183, which can
be considered suggestive, though not conclusive.
It should be noted that as the focus of the current study is on fine-
mapping of chromosome 3p and discovery of NGC as a novel
candidate gene, the genotyping coverage of the above interacting
partners (NRG1, ErbB3, and ErbB4) may not be comprehensive
enough. It is therefore possible that some susceptibility variants in
these genes were not captured.
The finding in the MDR analyses of significant statistical inter-
actions between SNPs at NGC and NRG1 is intriguing as these two
genes are both members of the neuregulin family and share ErbB3 as
a receptor. Thus it is plausible that they may play complementary or
synergistic roles in the pathogenesis of schizophrenia, for example,
in neurodevelopmental processes. Notably, the interaction between
this pair of SNPs was also confirmed by logistic regression and the
interaction was significant over the main effects. We also identified
two sets of 3-locus interactions between NRG1 and ErbB4, consis-
tent with the results of functional and association studies showing
these two genes interact. Statistical epistasis between the Icelandic
haplotype of NRG1 and a ErbB4 variant was previously reported by
Norton et al. [2006]. Interestingly, we found statistical interaction
between NGC and ErbB4 that was also modestly significant. Previ-
ous experiments showed that NGC directly binds to ErbB3 but not
to ErbB4. Although NGC and ErbB4 may not be direct interacting
partners, the two genes may be involved in complementary path-
ways related to brain development or other processes implicated in
SZ. NGC, NRG1, and ErbB4 may be part of a network regulating a
variety of processes involved in SZ.
Although these three-locus interactions were biologically plau-
sible and supported by MDR, they did not show significance when
logistic regression was used. This may be due to the different nature
of the two approaches. MDR is non-parametric and completely
model-free. MDR requires no mode of inheritance to be specified as
any multilocus genotype can be formed as the high-risk or low-risk
groups. It has high power to detect interactions in the absence of
main effects [Ritchie et al., 2003]. Despite being more flexible, the
genotype patterns identified by MDR may be very complex and
difficult to interpret. On the other hand, logistic regression is a form
of generalized linear model and does not involve partitioning of
genotype combinations into high-risk and low-risk groups. Logistic
regression may run into problems when dealing with large numbers
of SNPs as the number of possible interaction terms increases
rapidly with each additional SNP. Inclusion of too many indepen-
dent variables with respect to the number of outcome events
increases type 1 and type 2 errors [Peduzzi et al., 1996]. An
inheritance model is often assumed to limit the number of terms
in the regression model (we assumed an additive model in this
study). However, logistic regression has an advantage over MDR in
that it allows evaluation of interaction controlling for main
effects. In view of the substantial differences between the two
methods, some discrepancies between the test results are expected.
Nevertheless, one should also alert to the possibility of false
positives, particularly because we have included all SNPs regardless
TABLE V. Average Prediction Accuracies of the Best Combinations of SNPs Identified by MDR and Logistic Regression
SNP combination rs number of SNPs Testing accuracy MDR p Logistic regression P
2-SNP
1st NGC_3, NRG1_12 rs10865948, rs4733130 0.5711 0.015 0.009
2nd ErbB4_11, ErbB4_19 rs2371276, rs839530 0.5642 0.031 0.125
3rd ErbB4_11, NGC_1 rs2371276, rs7628631 0.5522 0.097 0.140
3-SNP
1st ErbB4_6, ErbB4_13, NRG1_8 rs10197225, rs6435659, rs2347504 0.5754 0.009 0.996
2nd ErbB4_3, ErbB4_11, NRG1_7 rs3748962, rs2371276, rs1545961 0.5751 0.009 0.409
3rd ErbB4_6, ErbB4_13, NGC_6 rs10197225, rs6435659, rs12489865 0.5617 0.043 0.295
P-values for MDR were derived from 1,000 permutations.
P-values for logistic regression were derived by comparing the full model (with all main effects and interaction terms) with the reduced model (with only the main effects). P< 0.05 are in bold.
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of whether they were independently associated with the disease. The
interactions identified in this study should not be regarded as
confirmatory and further association and functional studies are
required to clarify the findings.
ErbB3 was not found in the interacting pairs in this study.
However, its functional importance cannot be excluded. It is
possible that the functional variant has not been captured (e.g.,
the variant may be a rare one) or there may be variants lying outside
the gene which regulate its expression.
In summary, we have performed a high-density association
screen of a high-LD, gene-rich region on chromosome 3p and
discovered NGC as a novel candidate gene for SZ. A role for NGC in
SZ is supported by previous biological findings. Our methodology
demonstrates the use of tag SNPs, bioinformatics tools, weighted
FDR and MDR in association studies to identify new susceptibility
genes for complex diseases. Although our study provides statistical
evidence for the involvement of NGC and other candidate genes in
SZ, our results cannot be considered conclusive. Further replica-
tions, preferably with larger samples and in other populations, are
desirable for validation of our findings.
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